

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.45623900 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.45623900 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.87612139 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.62343067 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 5.05772445 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 5.05772445 |
| 7 | desmosome organization (GO:0002934) | 4.68168282 |
| 8 | response to type I interferon (GO:0034340) | 4.29399090 |
| 9 | type I interferon signaling pathway (GO:0060337) | 4.26871893 |
| 10 | cellular response to type I interferon (GO:0071357) | 4.26871893 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.20070453 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.20070453 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.20070453 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.20070453 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.20070453 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.20070453 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.14410410 |
| 18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.01374451 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94429953 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 3.91723031 |
| 21 | response to interferon-alpha (GO:0035455) | 3.90570225 |
| 22 | hemidesmosome assembly (GO:0031581) | 3.83280781 |
| 23 | signal peptide processing (GO:0006465) | 3.77491413 |
| 24 | basement membrane organization (GO:0071711) | 3.77348606 |
| 25 | protein maturation by protein folding (GO:0022417) | 3.69732846 |
| 26 | regulation of cholesterol homeostasis (GO:2000188) | 3.69308708 |
| 27 | regulation of extracellular matrix disassembly (GO:0010715) | 3.68317128 |
| 28 | proline biosynthetic process (GO:0006561) | 3.64380168 |
| 29 | response to interferon-beta (GO:0035456) | 3.62907764 |
| 30 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.61978562 |
| 31 | skin morphogenesis (GO:0043589) | 3.59274969 |
| 32 | barbed-end actin filament capping (GO:0051016) | 3.56686948 |
| 33 | NADH metabolic process (GO:0006734) | 3.53516108 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 3.52803034 |
| 35 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.52224343 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.42279753 |
| 37 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.37408847 |
| 38 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.37335387 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.34741612 |
| 40 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.22643437 |
| 41 | glucose 6-phosphate metabolic process (GO:0051156) | 3.16422000 |
| 42 | epithelial cell-cell adhesion (GO:0090136) | 3.16019378 |
| 43 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.13465787 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.11479424 |
| 45 | GDP-mannose metabolic process (GO:0019673) | 3.07137709 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06050854 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 3.05532994 |
| 48 | proline metabolic process (GO:0006560) | 3.04929942 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04919937 |
| 50 | regulation of cholesterol metabolic process (GO:0090181) | 3.04154293 |
| 51 | 4-hydroxyproline metabolic process (GO:0019471) | 3.03592771 |
| 52 | positive regulation of pseudopodium assembly (GO:0031274) | 3.02272624 |
| 53 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.00621310 |
| 54 | regulation of complement activation (GO:0030449) | 3.00570581 |
| 55 | cellular response to interferon-beta (GO:0035458) | 3.00554238 |
| 56 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.99831059 |
| 57 | regulation of apoptotic cell clearance (GO:2000425) | 2.97946763 |
| 58 | negative regulation of viral genome replication (GO:0045071) | 2.97800000 |
| 59 | semaphorin-plexin signaling pathway (GO:0071526) | 2.94438304 |
| 60 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.94283532 |
| 61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93807732 |
| 62 | protein carboxylation (GO:0018214) | 2.93807732 |
| 63 | protein retention in ER lumen (GO:0006621) | 2.93499044 |
| 64 | response to peptidoglycan (GO:0032494) | 2.92543003 |
| 65 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.92223137 |
| 66 | positive regulation of interferon-beta production (GO:0032728) | 2.91941499 |
| 67 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.91890058 |
| 68 | actin filament depolymerization (GO:0030042) | 2.91004474 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.90341600 |
| 70 | regulation of protein activation cascade (GO:2000257) | 2.90012425 |
| 71 | peptidyl-proline hydroxylation (GO:0019511) | 2.89476059 |
| 72 | response to host immune response (GO:0052572) | 2.88558537 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.88558537 |
| 74 | regulation of metalloenzyme activity (GO:0048552) | 2.88527859 |
| 75 | sequestering of metal ion (GO:0051238) | 2.87283256 |
| 76 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.86910481 |
| 77 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86163369 |
| 78 | endothelial cell morphogenesis (GO:0001886) | 2.85363221 |
| 79 | endothelial cell chemotaxis (GO:0035767) | 2.83554567 |
| 80 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.81620041 |
| 81 | positive regulation of antigen processing and presentation (GO:0002579) | 2.80069357 |
| 82 | regulation of extracellular matrix organization (GO:1903053) | 2.78031364 |
| 83 | protein hydroxylation (GO:0018126) | 2.77730805 |
| 84 | adhesion of symbiont to host (GO:0044406) | 2.75813621 |
| 85 | T-helper 1 type immune response (GO:0042088) | 2.75469458 |
| 86 | cell adhesion mediated by integrin (GO:0033627) | 2.75202510 |
| 87 | peptide hormone processing (GO:0016486) | 2.74151803 |
| 88 | renal filtration (GO:0097205) | 2.74037592 |
| 89 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.73069569 |
| 90 | COPII vesicle coating (GO:0048208) | 2.72309483 |
| 91 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.71480910 |
| 92 | toxin transport (GO:1901998) | 2.71209268 |
| 93 | extracellular fibril organization (GO:0043206) | 2.68379812 |
| 94 | L-serine transport (GO:0015825) | 2.67693874 |
| 95 | intestinal absorption (GO:0050892) | 2.67511621 |
| 96 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.66252076 |
| 97 | L-phenylalanine metabolic process (GO:0006558) | 2.66252076 |
| 98 | B cell mediated immunity (GO:0019724) | 2.65646020 |
| 99 | surfactant homeostasis (GO:0043129) | 2.64896545 |
| 100 | glucose catabolic process (GO:0006007) | 2.64700332 |
| 101 | cell-substrate junction assembly (GO:0007044) | 2.64464710 |
| 102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64302816 |
| 103 | amyloid precursor protein metabolic process (GO:0042982) | 2.63903021 |
| 104 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.61987111 |
| 105 | regulation of pseudopodium assembly (GO:0031272) | 2.61742172 |
| 106 | muscle cell migration (GO:0014812) | 2.61539307 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.60848480 |
| 108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.60535275 |
| 109 | response to host (GO:0075136) | 2.57582185 |
| 110 | response to host defenses (GO:0052200) | 2.57582185 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.57582185 |
| 112 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.55092386 |
| 113 | lung epithelium development (GO:0060428) | 2.55068699 |
| 114 | protein localization to endosome (GO:0036010) | 2.54652031 |
| 115 | regulation of RIG-I signaling pathway (GO:0039535) | 2.54525752 |
| 116 | positive regulation of macrophage differentiation (GO:0045651) | 2.54489252 |
| 117 | endosome to melanosome transport (GO:0035646) | 2.53737010 |
| 118 | endosome to pigment granule transport (GO:0043485) | 2.53737010 |
| 119 | regulation of antigen processing and presentation (GO:0002577) | 2.53333756 |
| 120 | activation of Rac GTPase activity (GO:0032863) | 2.53240481 |
| 121 | positive regulation of extracellular matrix organization (GO:1903055) | 2.52290371 |
| 122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.50075091 |
| 123 | membrane protein ectodomain proteolysis (GO:0006509) | 2.49490282 |
| 124 | regulation of cholesterol storage (GO:0010885) | 2.49157660 |
| 125 | fibril organization (GO:0097435) | 2.47164917 |
| 126 | complement activation, classical pathway (GO:0006958) | 2.46488654 |
| 127 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46234888 |
| 128 | regulation of cholesterol esterification (GO:0010872) | 2.45578729 |
| 129 | peptide catabolic process (GO:0043171) | 2.45274845 |
| 130 | detection of molecule of bacterial origin (GO:0032490) | 2.44272737 |
| 131 | cellular response to exogenous dsRNA (GO:0071360) | 2.44243847 |
| 132 | lung vasculature development (GO:0060426) | 2.44213564 |
| 133 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43097377 |
| 134 | regulation of response to interferon-gamma (GO:0060330) | 2.42782445 |
| 135 | positive regulation of osteoblast proliferation (GO:0033690) | 2.42567506 |
| 136 | pinocytosis (GO:0006907) | 2.41465914 |
| 137 | respiratory burst (GO:0045730) | 2.41280681 |
| 138 | response to interferon-gamma (GO:0034341) | 2.41053248 |
| 139 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.40835461 |
| 140 | negative regulation of cell size (GO:0045792) | 2.39575886 |
| 141 | cellular response to virus (GO:0098586) | 2.39569448 |
| 142 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.39495363 |
| 143 | keratan sulfate catabolic process (GO:0042340) | 2.39213833 |
| 144 | negative regulation of complement activation (GO:0045916) | 2.38690134 |
| 145 | negative regulation of protein activation cascade (GO:2000258) | 2.38318293 |
| 146 | low-density lipoprotein particle clearance (GO:0034383) | 2.36910260 |
| 147 | protein autoprocessing (GO:0016540) | 2.36657765 |
| 148 | cellular response to vitamin D (GO:0071305) | 2.36053163 |
| 149 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.35127339 |
| 150 | defense response to protozoan (GO:0042832) | 2.34821912 |
| 151 | angiotensin maturation (GO:0002003) | 2.34814543 |
| 152 | fibrinolysis (GO:0042730) | 2.33692322 |
| 153 | atrioventricular valve morphogenesis (GO:0003181) | 2.33533057 |
| 154 | T cell migration (GO:0072678) | 2.33368679 |
| 155 | positive regulation of nuclease activity (GO:0032075) | 2.33361106 |
| 156 | apoptotic cell clearance (GO:0043277) | 2.32993510 |
| 157 | myeloid cell activation involved in immune response (GO:0002275) | 2.32635269 |
| 158 | macrophage activation (GO:0042116) | 2.32292561 |
| 159 | serine transport (GO:0032329) | 2.31356537 |
| 160 | cellular response to interferon-alpha (GO:0035457) | 2.31338098 |
| 161 | cellular copper ion homeostasis (GO:0006878) | 2.31216356 |
| 162 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.30837945 |
| 163 | endocrine pancreas development (GO:0031018) | 2.30696998 |
| 164 | regulation of gamma-delta T cell activation (GO:0046643) | 2.30692739 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.30569061 |
| 166 | gap junction assembly (GO:0016264) | 2.30106385 |
| 167 | cellular response to vitamin (GO:0071295) | 2.29707838 |
| 168 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.29615461 |
| 169 | cellular response to interferon-gamma (GO:0071346) | 2.29536998 |
| 170 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.29016874 |
| 171 | sexual reproduction (GO:0019953) | 2.28643420 |
| 172 | amyloid precursor protein catabolic process (GO:0042987) | 2.27886416 |
| 173 | regulation of interferon-beta production (GO:0032648) | 2.27146855 |
| 174 | maintenance of protein localization in organelle (GO:0072595) | 2.26795426 |
| 175 | urea cycle (GO:0000050) | 2.26589042 |
| 176 | response to protozoan (GO:0001562) | 2.26556048 |
| 177 | positive regulation of receptor recycling (GO:0001921) | 2.26140033 |
| 178 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.25994363 |
| 179 | plasma lipoprotein particle assembly (GO:0034377) | 2.25386242 |
| 180 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.25289936 |
| 181 | virion attachment to host cell (GO:0019062) | 2.25216707 |
| 182 | adhesion of symbiont to host cell (GO:0044650) | 2.25216707 |
| 183 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.24802520 |
| 184 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.24802520 |
| 185 | lymphocyte chemotaxis (GO:0048247) | 2.24377085 |
| 186 | regulation of natural killer cell differentiation (GO:0032823) | 2.24013383 |
| 187 | defense response to virus (GO:0051607) | 2.23964038 |
| 188 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.23823423 |
| 189 | JAK-STAT cascade (GO:0007259) | 2.23820479 |
| 190 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.23621173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.10228525 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.34556745 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.75322163 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66726953 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.44152995 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.31525906 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22481704 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.07216910 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88711264 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86908319 |
| 11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79741930 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76578870 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.75449802 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.55625799 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49383752 |
| 16 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.44946980 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39095668 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.34249984 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30383269 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.23403764 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22291126 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.19111054 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18686168 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.15340526 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12059918 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11369241 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.09121128 |
| 28 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06522701 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04701779 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00305809 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99265147 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98632118 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97099408 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94916837 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.92623076 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91090968 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.87105217 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85714242 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84543754 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79296651 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77275012 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.73823446 |
| 43 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73257617 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.72353723 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71821179 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.71171026 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.69745144 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67311795 |
| 49 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.64764466 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63003765 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61940707 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61885246 |
| 53 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.61766814 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61367103 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61301144 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60068032 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55448843 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.55089473 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.54373000 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54058291 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53491471 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.53442505 |
| 63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53222351 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51769385 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51493076 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48500185 |
| 67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.47955935 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47617503 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47269626 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44113782 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43436030 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.42449236 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.41889368 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.41154822 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40707716 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40421183 |
| 77 | MYC_22102868_ChIP-Seq_BL_Human | 1.40191969 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.39179253 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38398695 |
| 80 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38371818 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.37957396 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37833297 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37416981 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37371135 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35711855 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34472040 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33905649 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33176104 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32625543 |
| 90 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32451717 |
| 91 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31908049 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30972033 |
| 93 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.30677756 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30107366 |
| 95 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29829968 |
| 96 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29723398 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29239928 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27897389 |
| 99 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.27319744 |
| 100 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27196836 |
| 101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.27067719 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26812080 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26735210 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26568338 |
| 105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26511848 |
| 106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26442512 |
| 107 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.25329492 |
| 108 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.25089787 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24765354 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23445815 |
| 111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23277376 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22296113 |
| 113 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.22097792 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21951339 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21245017 |
| 116 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21019037 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21019037 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20562834 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20470730 |
| 120 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20413907 |
| 121 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17797553 |
| 122 | * P68_20966046_ChIP-Seq_HELA_Human | 1.15604732 |
| 123 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15524779 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15243026 |
| 125 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14853889 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14139909 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13618282 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13565600 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12903377 |
| 130 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12884852 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12736203 |
| 132 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12562243 |
| 133 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12347023 |
| 134 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12236707 |
| 135 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11600000 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10942221 |
| 137 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10569645 |
| 138 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09999986 |
| 139 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09990146 |
| 140 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09651695 |
| 141 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09035654 |
| 142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08469094 |
| 143 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07925496 |
| 144 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07925496 |
| 145 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07757913 |
| 146 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07724538 |
| 147 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07491845 |
| 148 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05706078 |
| 149 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05550133 |
| 150 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05271348 |
| 151 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05241324 |
| 152 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.04903159 |
| 153 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02643548 |
| 154 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02258274 |
| 155 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01837906 |
| 156 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01722411 |
| 157 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00649332 |
| 158 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.99408296 |
| 159 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99066217 |
| 160 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98319934 |
| 161 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97974623 |
| 162 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97649793 |
| 163 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97144324 |
| 164 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96597093 |
| 165 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96407229 |
| 166 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95456727 |
| 167 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.94113730 |
| 168 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93716606 |
| 169 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93016099 |
| 170 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92497719 |
| 171 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87680469 |
| 172 | MAF_26560356_Chip-Seq_TH2_Human | 0.86081079 |
| 173 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85437310 |
| 174 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85298860 |
| 175 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83855143 |
| 176 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82198073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 3.36375617 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.31588004 |
| 3 | MP0004272_abnormal_basement_membrane | 3.29830827 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.28350312 |
| 5 | MP0003724_increased_susceptibility_to | 3.03585769 |
| 6 | MP0009785_altered_susceptibility_to | 2.80593850 |
| 7 | MP0003436_decreased_susceptibility_to | 2.58807479 |
| 8 | MP0000685_abnormal_immune_system | 2.39607070 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.30900517 |
| 10 | MP0006082_CNS_inflammation | 2.29707289 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.28092225 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.23930199 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.23655097 |
| 14 | MP0005025_abnormal_response_to | 2.23446501 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.23227569 |
| 16 | MP0009840_abnormal_foam_cell | 2.20144997 |
| 17 | MP0005671_abnormal_response_to | 2.18204029 |
| 18 | MP0001790_abnormal_immune_system | 2.17862192 |
| 19 | MP0005387_immune_system_phenotype | 2.17862192 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.17681800 |
| 21 | MP0002419_abnormal_innate_immunity | 2.15937564 |
| 22 | MP0005670_abnormal_white_adipose | 2.11889579 |
| 23 | MP0003195_calcinosis | 2.11161382 |
| 24 | MP0000751_myopathy | 2.07448798 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.04666505 |
| 26 | MP0005409_darkened_coat_color | 2.01699355 |
| 27 | MP0004858_abnormal_nervous_system | 1.91748140 |
| 28 | MP0001849_ear_inflammation | 1.90290017 |
| 29 | MP0000566_synostosis | 1.89725483 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.88855298 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.87733119 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.86373947 |
| 33 | MP0002060_abnormal_skin_morphology | 1.86124910 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.83101962 |
| 35 | MP0006054_spinal_hemorrhage | 1.79360621 |
| 36 | * MP0002723_abnormal_immune_serum | 1.78831127 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.78479046 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.78440859 |
| 39 | MP0001800_abnormal_humoral_immune | 1.74081389 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.73610273 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.73181327 |
| 42 | MP0005171_absent_coat_pigmentation | 1.71592570 |
| 43 | MP0005408_hypopigmentation | 1.70873973 |
| 44 | MP0004947_skin_inflammation | 1.68319758 |
| 45 | MP0002693_abnormal_pancreas_physiology | 1.67716850 |
| 46 | MP0005451_abnormal_body_composition | 1.67539838 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.64632887 |
| 48 | MP0001819_abnormal_immune_cell | 1.61155960 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.59906973 |
| 50 | MP0003303_peritoneal_inflammation | 1.58842204 |
| 51 | * MP0001845_abnormal_inflammatory_respons | 1.58449748 |
| 52 | * MP0008469_abnormal_protein_level | 1.58232348 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.55996989 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.55375963 |
| 55 | MP0003329_amyloid_beta_deposits | 1.53866161 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.52498893 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.50092657 |
| 58 | MP0002405_respiratory_system_inflammati | 1.47219330 |
| 59 | MP0004510_myositis | 1.46901471 |
| 60 | MP0008260_abnormal_autophagy | 1.45074687 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.44511797 |
| 62 | MP0002006_tumorigenesis | 1.43129094 |
| 63 | MP0005310_abnormal_salivary_gland | 1.42035539 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.38932691 |
| 65 | MP0000537_abnormal_urethra_morphology | 1.37350741 |
| 66 | MP0005275_abnormal_skin_tensile | 1.34494052 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.33836523 |
| 68 | MP0000343_altered_response_to | 1.32661268 |
| 69 | MP0002796_impaired_skin_barrier | 1.32450271 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.32393167 |
| 71 | MP0005365_abnormal_bile_salt | 1.31945752 |
| 72 | MP0005330_cardiomyopathy | 1.30660775 |
| 73 | MP0005165_increased_susceptibility_to | 1.30410324 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 1.30145736 |
| 75 | MP0002933_joint_inflammation | 1.29375240 |
| 76 | MP0003763_abnormal_thymus_physiology | 1.29017028 |
| 77 | MP0001944_abnormal_pancreas_morphology | 1.28632187 |
| 78 | MP0002896_abnormal_bone_mineralization | 1.26148023 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 1.26114993 |
| 80 | MP0000858_altered_metastatic_potential | 1.25737600 |
| 81 | MP0009643_abnormal_urine_homeostasis | 1.25505715 |
| 82 | MP0000716_abnormal_immune_system | 1.24334687 |
| 83 | MP0002398_abnormal_bone_marrow | 1.20421740 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 1.20132404 |
| 85 | MP0005375_adipose_tissue_phenotype | 1.19511740 |
| 86 | MP0005666_abnormal_adipose_tissue | 1.18359864 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 1.18241921 |
| 88 | MP0003091_abnormal_cell_migration | 1.18219470 |
| 89 | MP0005501_abnormal_skin_physiology | 1.17177745 |
| 90 | MP0002998_abnormal_bone_remodeling | 1.15334617 |
| 91 | MP0009764_decreased_sensitivity_to | 1.15065611 |
| 92 | MP0005076_abnormal_cell_differentiation | 1.14801438 |
| 93 | MP0003866_abnormal_defecation | 1.14222681 |
| 94 | MP0000762_abnormal_tongue_morphology | 1.12461243 |
| 95 | MP0001853_heart_inflammation | 1.11743326 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 1.09728225 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 1.09722094 |
| 98 | MP0001545_abnormal_hematopoietic_system | 1.09722094 |
| 99 | MP0003252_abnormal_bile_duct | 1.09300215 |
| 100 | MP0000609_abnormal_liver_physiology | 1.06521966 |
| 101 | MP0005085_abnormal_gallbladder_physiolo | 1.06270131 |
| 102 | MP0000467_abnormal_esophagus_morphology | 1.05443495 |
| 103 | MP0001216_abnormal_epidermal_layer | 1.05374269 |
| 104 | MP0002429_abnormal_blood_cell | 1.05048237 |
| 105 | MP0003448_altered_tumor_morphology | 1.04591761 |
| 106 | MP0000689_abnormal_spleen_morphology | 1.04460773 |
| 107 | MP0005508_abnormal_skeleton_morphology | 1.01971406 |
| 108 | MP0003186_abnormal_redox_activity | 1.01722685 |
| 109 | MP0000003_abnormal_adipose_tissue | 1.01109992 |
| 110 | MP0006138_congestive_heart_failure | 0.99322228 |
| 111 | MP0003045_fibrosis | 0.98418651 |
| 112 | MP0002722_abnormal_immune_system | 0.97406507 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.97243699 |
| 114 | MP0003075_altered_response_to | 0.96437464 |
| 115 | MP0001756_abnormal_urination | 0.96332302 |
| 116 | MP0001873_stomach_inflammation | 0.96070395 |
| 117 | MP0000462_abnormal_digestive_system | 0.94126254 |
| 118 | MP0010329_abnormal_lipoprotein_level | 0.93932190 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.93603922 |
| 120 | MP0000604_amyloidosis | 0.93539929 |
| 121 | MP0001661_extended_life_span | 0.93512370 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.90953236 |
| 123 | MP0005164_abnormal_response_to | 0.90649104 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.90362409 |
| 125 | MP0000579_abnormal_nail_morphology | 0.90036483 |
| 126 | MP0009763_increased_sensitivity_to | 0.89556911 |
| 127 | MP0005390_skeleton_phenotype | 0.89373274 |
| 128 | MP0005257_abnormal_intraocular_pressure | 0.89057902 |
| 129 | MP0003795_abnormal_bone_structure | 0.88345036 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.88288305 |
| 131 | MP0002118_abnormal_lipid_homeostasis | 0.86379932 |
| 132 | MP0002098_abnormal_vibrissa_morphology | 0.86333526 |
| 133 | MP0005503_abnormal_tendon_morphology | 0.86323231 |
| 134 | MP0005360_urolithiasis | 0.85417659 |
| 135 | MP0000534_abnormal_ureter_morphology | 0.85071649 |
| 136 | MP0005083_abnormal_biliary_tract | 0.83695208 |
| 137 | MP0003950_abnormal_plasma_membrane | 0.83509608 |
| 138 | MP0003123_paternal_imprinting | 0.83324804 |
| 139 | MP0003705_abnormal_hypodermis_morpholog | 0.83006630 |
| 140 | MP0000767_abnormal_smooth_muscle | 0.82724549 |
| 141 | MP0005023_abnormal_wound_healing | 0.82545373 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.81032286 |
| 143 | MP0001666_abnormal_nutrient_absorption | 0.80846333 |
| 144 | MP0002136_abnormal_kidney_physiology | 0.80653106 |
| 145 | MP0001958_emphysema | 0.79448250 |
| 146 | MP0004782_abnormal_surfactant_physiolog | 0.79400280 |
| 147 | MP0004185_abnormal_adipocyte_glucose | 0.79184998 |
| 148 | MP0003279_aneurysm | 0.77589997 |
| 149 | MP0002928_abnormal_bile_duct | 0.77495936 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.77376167 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.77055869 |
| 152 | MP0000490_abnormal_crypts_of | 0.76782537 |
| 153 | MP0009278_abnormal_bone_marrow | 0.76736042 |
| 154 | MP0000681_abnormal_thyroid_gland | 0.75755215 |
| 155 | MP0010771_integument_phenotype | 0.74676661 |
| 156 | MP0005197_abnormal_uvea_morphology | 0.74133305 |
| 157 | MP0003315_abnormal_perineum_morphology | 0.72495385 |
| 158 | MP0002971_abnormal_brown_adipose | 0.72053400 |
| 159 | MP0005332_abnormal_amino_acid | 0.71545803 |
| 160 | MP0002970_abnormal_white_adipose | 0.70741705 |
| 161 | MP0002249_abnormal_larynx_morphology | 0.70738366 |
| 162 | MP0000477_abnormal_intestine_morphology | 0.70401160 |
| 163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70318148 |
| 164 | MP0003634_abnormal_glial_cell | 0.69881798 |
| 165 | MP0001664_abnormal_digestion | 0.67176284 |
| 166 | MP0005166_decreased_susceptibility_to | 0.65714032 |
| 167 | MP0000538_abnormal_urinary_bladder | 0.65627357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dysostosis multiplex (HP:0000943) | 4.85514440 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.70758307 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.50355370 |
| 4 | Mucopolysacchariduria (HP:0008155) | 4.46382437 |
| 5 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.46382437 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.28064821 |
| 7 | Protrusio acetabuli (HP:0003179) | 4.20632663 |
| 8 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.10850884 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.10850884 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.10850884 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.82312262 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.65315895 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.63467332 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.60548173 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.58659334 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.54954877 |
| 17 | Chronic otitis media (HP:0000389) | 3.35162023 |
| 18 | Cerebral aneurysm (HP:0004944) | 3.24648716 |
| 19 | Myositis (HP:0100614) | 3.24540473 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.24235173 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.15533710 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13598213 |
| 23 | Distal upper limb amyotrophy (HP:0007149) | 3.05843548 |
| 24 | Upper limb amyotrophy (HP:0009129) | 3.05843548 |
| 25 | Hemorrhage of the eye (HP:0011885) | 2.94582782 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 2.93265795 |
| 27 | Hypoglycemic seizures (HP:0002173) | 2.90463685 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.88117550 |
| 29 | Xanthomatosis (HP:0000991) | 2.86934719 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.86275515 |
| 31 | Atrophic scars (HP:0001075) | 2.85740557 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 2.84941196 |
| 33 | Nasal polyposis (HP:0100582) | 2.80859950 |
| 34 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.79933340 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.76090177 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73996431 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73996431 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73996431 |
| 39 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.70166936 |
| 40 | Glomerulonephritis (HP:0000099) | 2.69877132 |
| 41 | Short nail (HP:0001799) | 2.69147512 |
| 42 | Vascular calcification (HP:0004934) | 2.67506956 |
| 43 | J-shaped sella turcica (HP:0002680) | 2.66810206 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 2.66479460 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.64020048 |
| 46 | Retinal atrophy (HP:0001105) | 2.63275482 |
| 47 | Late onset (HP:0003584) | 2.59961859 |
| 48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.59779656 |
| 49 | Complement deficiency (HP:0004431) | 2.59316938 |
| 50 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.57517152 |
| 51 | Cervical subluxation (HP:0003308) | 2.52369172 |
| 52 | Orchitis (HP:0100796) | 2.52354763 |
| 53 | Symptomatic seizures (HP:0011145) | 2.52037293 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.51232182 |
| 55 | Broad face (HP:0000283) | 2.48065292 |
| 56 | Progressive neurologic deterioration (HP:0002344) | 2.46633870 |
| 57 | Osteolytic defects of the hand bones (HP:0009699) | 2.45382097 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45382097 |
| 59 | Beaking of vertebral bodies (HP:0004568) | 2.45008583 |
| 60 | Mitral stenosis (HP:0001718) | 2.43887756 |
| 61 | Fragile skin (HP:0001030) | 2.43829265 |
| 62 | Hand muscle atrophy (HP:0009130) | 2.41228064 |
| 63 | Abnormality of the Achilles tendon (HP:0005109) | 2.40840763 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.40340630 |
| 65 | Increased connective tissue (HP:0009025) | 2.39578904 |
| 66 | Petechiae (HP:0000967) | 2.39457796 |
| 67 | Achilles tendon contracture (HP:0001771) | 2.38865863 |
| 68 | Axonal loss (HP:0003447) | 2.38656790 |
| 69 | Flat acetabular roof (HP:0003180) | 2.37883582 |
| 70 | Recurrent fungal infections (HP:0002841) | 2.37114397 |
| 71 | Ulnar bowing (HP:0003031) | 2.36357449 |
| 72 | Abnormality of carpal bone ossification (HP:0006257) | 2.35659312 |
| 73 | Loss of speech (HP:0002371) | 2.34305073 |
| 74 | Basal ganglia calcification (HP:0002135) | 2.33999656 |
| 75 | Vertebral compression fractures (HP:0002953) | 2.33866580 |
| 76 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.32959967 |
| 77 | Thrombocytosis (HP:0001894) | 2.32267061 |
| 78 | Hyperacusis (HP:0010780) | 2.32045200 |
| 79 | Arterial tortuosity (HP:0005116) | 2.31839623 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.31794557 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.30897240 |
| 82 | Pustule (HP:0200039) | 2.30846397 |
| 83 | Focal segmental glomerulosclerosis (HP:0000097) | 2.29393223 |
| 84 | Nuclear cataract (HP:0100018) | 2.28566741 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.27721944 |
| 86 | Abnormality of complement system (HP:0005339) | 2.27639218 |
| 87 | Recurrent viral infections (HP:0004429) | 2.26237501 |
| 88 | Asymmetric septal hypertrophy (HP:0001670) | 2.25424717 |
| 89 | Recurrent skin infections (HP:0001581) | 2.25304444 |
| 90 | Gingivitis (HP:0000230) | 2.24895922 |
| 91 | Wormian bones (HP:0002645) | 2.24577613 |
| 92 | Periodontitis (HP:0000704) | 2.23455186 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.22229759 |
| 94 | Hydroxyprolinuria (HP:0003080) | 2.22229759 |
| 95 | IgM deficiency (HP:0002850) | 2.20233262 |
| 96 | Trismus (HP:0000211) | 2.18011117 |
| 97 | Ketoacidosis (HP:0001993) | 2.16927936 |
| 98 | Vascular tortuosity (HP:0004948) | 2.16854058 |
| 99 | Coxa vara (HP:0002812) | 2.16739607 |
| 100 | Hyperglycemia (HP:0003074) | 2.16205759 |
| 101 | Cholecystitis (HP:0001082) | 2.15403006 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 2.15403006 |
| 103 | Growth hormone excess (HP:0000845) | 2.15094782 |
| 104 | Gingival bleeding (HP:0000225) | 2.13279388 |
| 105 | Abnormality of the intrinsic pathway (HP:0010989) | 2.12496811 |
| 106 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.12364899 |
| 107 | Spontaneous hematomas (HP:0007420) | 2.11764229 |
| 108 | Acanthosis nigricans (HP:0000956) | 2.11294411 |
| 109 | Glomerulosclerosis (HP:0000096) | 2.09320791 |
| 110 | Glucose intolerance (HP:0000833) | 2.08408062 |
| 111 | Joint stiffness (HP:0001387) | 2.07984891 |
| 112 | Amyloidosis (HP:0011034) | 2.07407183 |
| 113 | Stridor (HP:0010307) | 2.07273524 |
| 114 | Aneurysm (HP:0002617) | 2.05055548 |
| 115 | Skin nodule (HP:0200036) | 2.04985373 |
| 116 | Hypergammaglobulinemia (HP:0010702) | 2.03150125 |
| 117 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02765824 |
| 118 | Elbow flexion contracture (HP:0002987) | 2.02587190 |
| 119 | Autoimmune hemolytic anemia (HP:0001890) | 2.01177085 |
| 120 | Pterygium (HP:0001059) | 2.00901461 |
| 121 | Abnormality of T cells (HP:0002843) | 1.98958673 |
| 122 | Abnormal ossification of hand bones (HP:0005921) | 1.98887602 |
| 123 | Vasculitis (HP:0002633) | 1.98354477 |
| 124 | Spondylolisthesis (HP:0003302) | 1.97496717 |
| 125 | Hypokinesia (HP:0002375) | 1.96856874 |
| 126 | Abdominal distention (HP:0003270) | 1.96584349 |
| 127 | Alopecia of scalp (HP:0002293) | 1.94099615 |
| 128 | Hypercholesterolemia (HP:0003124) | 1.93741003 |
| 129 | Aortic dissection (HP:0002647) | 1.93525781 |
| 130 | Paraparesis (HP:0002385) | 1.93016840 |
| 131 | Neurofibrillary tangles (HP:0002185) | 1.92589797 |
| 132 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.91597697 |
| 133 | Epistaxis (HP:0000421) | 1.91592089 |
| 134 | Spinal rigidity (HP:0003306) | 1.91341999 |
| 135 | Ovoid vertebral bodies (HP:0003300) | 1.91222924 |
| 136 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90520863 |
| 137 | Blue sclerae (HP:0000592) | 1.90199231 |
| 138 | Abnormality of the acetabulum (HP:0003170) | 1.89778496 |
| 139 | Bladder diverticulum (HP:0000015) | 1.87405956 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.86202322 |
| 141 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.85645072 |
| 142 | Inflammation of the large intestine (HP:0002037) | 1.85477270 |
| 143 | Gastrointestinal inflammation (HP:0004386) | 1.84866003 |
| 144 | Tetraparesis (HP:0002273) | 1.84596817 |
| 145 | Biconcave vertebral bodies (HP:0004586) | 1.83525902 |
| 146 | Advanced eruption of teeth (HP:0006288) | 1.83216831 |
| 147 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.83211624 |
| 148 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.83211624 |
| 149 | Large for gestational age (HP:0001520) | 1.83023805 |
| 150 | Joint hemorrhage (HP:0005261) | 1.82594507 |
| 151 | Natal tooth (HP:0000695) | 1.82474492 |
| 152 | Joint swelling (HP:0001386) | 1.82404579 |
| 153 | Malnutrition (HP:0004395) | 1.82278206 |
| 154 | Impaired platelet aggregation (HP:0003540) | 1.82201096 |
| 155 | Abnormal platelet function (HP:0011869) | 1.82201096 |
| 156 | Purpura (HP:0000979) | 1.82181891 |
| 157 | Hematochezia (HP:0002573) | 1.81978403 |
| 158 | Abnormality of dentin (HP:0010299) | 1.80842977 |
| 159 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.79941692 |
| 160 | Abnormal glucose tolerance (HP:0001952) | 1.79162642 |
| 161 | Chronic diarrhea (HP:0002028) | 1.79055725 |
| 162 | Hypertriglyceridemia (HP:0002155) | 1.78779818 |
| 163 | Pulmonary infiltrates (HP:0002113) | 1.77701993 |
| 164 | Myocardial infarction (HP:0001658) | 1.77044143 |
| 165 | Shallow orbits (HP:0000586) | 1.76768522 |
| 166 | Hypoplasia of the thymus (HP:0000778) | 1.76467129 |
| 167 | Nephritis (HP:0000123) | 1.76362546 |
| 168 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.75350667 |
| 169 | Pathologic fracture (HP:0002756) | 1.75264273 |
| 170 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75219405 |
| 171 | Retrobulbar optic neuritis (HP:0100654) | 1.74805909 |
| 172 | Optic neuritis (HP:0100653) | 1.74805909 |
| 173 | Cardiomegaly (HP:0001640) | 1.74330962 |
| 174 | Increased IgM level (HP:0003496) | 1.73653431 |
| 175 | Abnormal protein glycosylation (HP:0012346) | 1.73001440 |
| 176 | Abnormal glycosylation (HP:0012345) | 1.73001440 |
| 177 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.73001440 |
| 178 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.73001440 |
| 179 | Prolonged neonatal jaundice (HP:0006579) | 1.71785285 |
| 180 | Generalized amyotrophy (HP:0003700) | 1.71357138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.65176403 |
| 2 | ERN1 | 4.19256254 |
| 3 | TAOK3 | 3.27250498 |
| 4 | LMTK2 | 3.11588920 |
| 5 | TBK1 | 2.96385656 |
| 6 | MAPK15 | 2.91345122 |
| 7 | TYK2 | 2.81644726 |
| 8 | MAP4K1 | 2.63157043 |
| 9 | KIT | 2.62634885 |
| 10 | JAK3 | 2.38695856 |
| 11 | ICK | 2.32011918 |
| 12 | IKBKE | 2.25876147 |
| 13 | ZAP70 | 2.23014812 |
| 14 | FGFR4 | 2.16679585 |
| 15 | FLT3 | 2.15778954 |
| 16 | IRAK3 | 2.09923628 |
| 17 | JAK1 | 2.09375544 |
| 18 | TGFBR2 | 2.00350227 |
| 19 | BLK | 1.99810618 |
| 20 | IRAK4 | 1.95624566 |
| 21 | TRIB3 | 1.93291616 |
| 22 | SMG1 | 1.91535840 |
| 23 | PIK3CG | 1.91133394 |
| 24 | INSRR | 1.83500159 |
| 25 | PIM2 | 1.68480202 |
| 26 | PASK | 1.61510902 |
| 27 | MAP3K14 | 1.59155490 |
| 28 | TEC | 1.56483133 |
| 29 | LIMK1 | 1.54476876 |
| 30 | TXK | 1.54449765 |
| 31 | EPHB2 | 1.53372918 |
| 32 | BTK | 1.53258426 |
| 33 | SCYL2 | 1.52777738 |
| 34 | NME2 | 1.49309921 |
| 35 | FRK | 1.43193894 |
| 36 | KDR | 1.38667898 |
| 37 | DDR2 | 1.37621250 |
| 38 | EPHA3 | 1.34904462 |
| 39 | HIPK2 | 1.34087534 |
| 40 | WNK3 | 1.26132442 |
| 41 | CSK | 1.24529845 |
| 42 | RIPK1 | 1.23564275 |
| 43 | PKN2 | 1.19039055 |
| 44 | IKBKB | 1.13468597 |
| 45 | PTK6 | 1.12800019 |
| 46 | EPHB1 | 1.12536749 |
| 47 | NTRK1 | 1.12471976 |
| 48 | NEK9 | 1.12162404 |
| 49 | CSF1R | 1.11069611 |
| 50 | RPS6KA4 | 1.10383119 |
| 51 | SYK | 1.06434117 |
| 52 | JAK2 | 1.06035374 |
| 53 | FGFR3 | 1.05520631 |
| 54 | MAP2K3 | 1.04802391 |
| 55 | MAP3K1 | 1.02828087 |
| 56 | CAMKK2 | 1.02461895 |
| 57 | ARAF | 1.00669086 |
| 58 | PRPF4B | 1.00293032 |
| 59 | ITK | 0.98785575 |
| 60 | SIK1 | 0.97103111 |
| 61 | LRRK2 | 0.92908540 |
| 62 | LCK | 0.90311165 |
| 63 | MAP3K3 | 0.88604343 |
| 64 | FER | 0.87026445 |
| 65 | MST1R | 0.86799365 |
| 66 | TGFBR1 | 0.86318138 |
| 67 | PRKG2 | 0.86090131 |
| 68 | CDC42BPA | 0.84835738 |
| 69 | LYN | 0.83766862 |
| 70 | TAOK2 | 0.80780976 |
| 71 | HCK | 0.79732496 |
| 72 | IRAK1 | 0.79695846 |
| 73 | NLK | 0.79180326 |
| 74 | BCKDK | 0.79175963 |
| 75 | CDK12 | 0.78492505 |
| 76 | CHUK | 0.78382221 |
| 77 | ERBB4 | 0.75525787 |
| 78 | LATS2 | 0.73201872 |
| 79 | PTK2 | 0.73156251 |
| 80 | DYRK1B | 0.71552493 |
| 81 | MAP3K13 | 0.70642267 |
| 82 | MAP3K2 | 0.70226320 |
| 83 | MTOR | 0.69585095 |
| 84 | EEF2K | 0.68496787 |
| 85 | PDPK1 | 0.67496346 |
| 86 | MATK | 0.66804137 |
| 87 | TESK1 | 0.66647406 |
| 88 | TIE1 | 0.65747648 |
| 89 | MAP3K6 | 0.64020525 |
| 90 | ILK | 0.61573281 |
| 91 | PDK2 | 0.60979276 |
| 92 | CDK8 | 0.58797569 |
| 93 | MAPKAPK3 | 0.58320809 |
| 94 | MAP2K2 | 0.58116611 |
| 95 | CAMK1D | 0.57360389 |
| 96 | PRKD2 | 0.55739927 |
| 97 | PRKCI | 0.54378828 |
| 98 | DAPK1 | 0.54334890 |
| 99 | PDGFRA | 0.54265125 |
| 100 | PAK4 | 0.53511895 |
| 101 | PRKCH | 0.52195392 |
| 102 | CAMK2G | 0.51961769 |
| 103 | CDK7 | 0.50668328 |
| 104 | MAP3K11 | 0.49781442 |
| 105 | STK10 | 0.49228975 |
| 106 | MAP3K12 | 0.49225641 |
| 107 | STK38 | 0.48672957 |
| 108 | PRKD3 | 0.45873269 |
| 109 | MAPK11 | 0.45734553 |
| 110 | VRK2 | 0.45721205 |
| 111 | RIPK4 | 0.45341674 |
| 112 | PHKG2 | 0.44267015 |
| 113 | PHKG1 | 0.44267015 |
| 114 | IGF1R | 0.43508448 |
| 115 | CAMK2D | 0.41305827 |
| 116 | MAP3K10 | 0.40619043 |
| 117 | ERBB2 | 0.40253469 |
| 118 | PRKCD | 0.40146306 |
| 119 | RET | 0.39637533 |
| 120 | RPS6KA2 | 0.39162020 |
| 121 | DMPK | 0.38716117 |
| 122 | PIM1 | 0.38312422 |
| 123 | MAP2K6 | 0.36819986 |
| 124 | EIF2AK1 | 0.36117931 |
| 125 | MET | 0.35939801 |
| 126 | GSK3A | 0.35682381 |
| 127 | ROCK2 | 0.35233175 |
| 128 | BRSK1 | 0.34338311 |
| 129 | ADRBK2 | 0.33515216 |
| 130 | SRC | 0.32123906 |
| 131 | RPS6KB2 | 0.32040254 |
| 132 | NME1 | 0.31872653 |
| 133 | PRKD1 | 0.31468485 |
| 134 | EGFR | 0.31019777 |
| 135 | MAPKAPK2 | 0.30710610 |
| 136 | PAK1 | 0.30540438 |
| 137 | MUSK | 0.29868639 |
| 138 | CDK9 | 0.29705720 |
| 139 | FES | 0.29577684 |
| 140 | EIF2AK3 | 0.29009518 |
| 141 | CDK6 | 0.28926657 |
| 142 | ABL1 | 0.28581170 |
| 143 | PDGFRB | 0.28333798 |
| 144 | ABL2 | 0.28321444 |
| 145 | TESK2 | 0.28059038 |
| 146 | LATS1 | 0.27120625 |
| 147 | WNK4 | 0.25569028 |
| 148 | ROCK1 | 0.25325652 |
| 149 | MELK | 0.25143089 |
| 150 | BMX | 0.24996637 |
| 151 | MYLK | 0.24258328 |
| 152 | MAP3K8 | 0.24231625 |
| 153 | AKT2 | 0.23998639 |
| 154 | BRSK2 | 0.23840652 |
| 155 | RPS6KA5 | 0.23056625 |
| 156 | TTN | 0.22732904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.11925032 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.65201217 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.24866103 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.00617399 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.79609320 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.78209699 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.47916082 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.37099890 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28236841 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24744571 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19769335 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.16448215 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01361798 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95253900 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.91974166 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91063072 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87738389 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.81666214 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.81387710 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.80838447 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.76543574 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.73879006 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72223440 |
| 24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.71728795 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.70226892 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.69952321 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67311397 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66376972 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66002861 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57615085 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55873855 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.54500052 |
| 33 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.54161148 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46033513 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43591713 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40740622 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.40586372 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37477381 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35230634 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.34335281 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32711156 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.32652505 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.31864740 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31811605 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29454132 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.29017585 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.28478282 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24186100 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23609037 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22656454 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.21113812 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20378556 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19871377 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19398250 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.19352099 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17180439 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17100667 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15851182 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15803490 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13534837 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13281370 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10706482 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.09764590 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 1.08088428 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06769917 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04538910 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 1.03998485 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02942692 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 1.02219293 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 1.00195881 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99715515 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.98266266 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97857221 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96627089 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.96568186 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95194955 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92924814 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.92448395 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91866214 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91155043 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90930085 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89334766 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.89023237 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.88995912 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85944345 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85821455 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.83575643 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81099169 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.80148786 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.79763910 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79555809 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79057536 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78230999 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76179003 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75645119 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.75342715 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74958550 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74732135 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.73676140 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73624649 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71983054 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71722752 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71364029 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68266458 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67992262 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65691555 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65396644 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65396219 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64770230 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64120824 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62837690 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62641404 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.62314325 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61456280 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59845589 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58458606 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57903176 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.57860561 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57796703 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56297284 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55469700 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55365677 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54744170 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.54661564 |
| 125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53868152 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.52726910 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52546678 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52463465 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50994044 |
| 130 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50946983 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50936195 |
| 132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49486718 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.48966954 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47882752 |
| 135 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46762978 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46199748 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45148596 |
| 138 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45027759 |
| 139 | Lysine degradation_Homo sapiens_hsa00310 | 0.43281805 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42716970 |
| 141 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42266344 |
| 142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41014650 |
| 143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40659048 |
| 144 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38934952 |
| 145 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38235665 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35955619 |
| 147 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35699686 |
| 148 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33138783 |
| 149 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32880584 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32845912 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32486826 |
| 152 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32409332 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.30513119 |
| 154 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29713839 |
| 155 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29298748 |
| 156 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29063266 |
| 157 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29033369 |
| 158 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28875412 |
| 159 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26994078 |

